Showing results (1-10 of 346) with videos related to
Sort By:
Pageof 35
Onkologie|May 18, 2011
Prophylactic application of nebulized liposomal amphotericin B in hematologic patients with neutropeniaAnnette Hullard-Pulstinger, Ernst Holler, Joachim Hahn, et al.Molecular and Clinical Oncology|March 21, 2014
Regression of eosinophil counts after diagnosis of chronic graft-versus-host disease as a potential marker for improved clinical outcomeFabian Beier, Klaus Arbter, Nicolai A Kittan, et al.Best Practice & Research. Clinical Haematology|April 24, 2007
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatmentErnst HollerCurrent Opinion in Hematology|September 28, 2007
Progress in acute graft versus host diseaseErnst HollerCurrent Opinion in Hematology|October 24, 2002
Cytokines, viruses, and graft-versus-host diseaseErnst HollerMethods in Molecular Medicine|August 2, 2007
Polymorphisms within epithelial receptors: NOD2/CARD15Julia Brenmoehl, Ernst Holler, Gerhard RoglerCurrent Opinion in Oncology|June 30, 2009
Pathophysiology and management of graft-versus-host disease in the era of reduced-intensity conditioningKarin Landfried, Daniel Wolff, Ernst HollerImmunobiology|January 22, 2013
Beta-defensins activate macrophages and synergize in pro-inflammatory cytokine expression induced by TLR ligandsNicola Barabas, Johann Röhrl, Ernst Holler, et al.Journal of Molecular Medicine (Berlin, Germany)|May 17, 2011
Danger signals activating innate immunity in graft-versus-host diseaseRobert Zeiser, Olaf Penack, Ernst Holler, et al.Immunobiology|July 6, 2016
Human beta-defensin-2 and -3 enhance pro-inflammatory cytokine expression induced by TLR ligands via ATP-release in a P2X7R dependent mannerDaniela Wanke, Katrin Mauch-Mücke, Ernst Holler, et al.Pageof 35